209 242

Cited 20 times in

Hyperleptinemia as a robust risk factor of coronary artery disease and metabolic syndrome in type 2 diabetic patients.

 Soo-Kyung KIM  ;  Hae-Jin KIM  ;  Chul-Woo AHN  ;  Seok-Won PARK  ;  Yong-Wook CHO  ;  Sung-Kil LIM  ;  Hyun-Chul LEE  ;  Bong-Soo CHA 
 ENDOCRINE JOURNAL, Vol.55(6) : 1085-1092, 2008 
Journal Title
Issue Date
Adult ; Coronary Artery Disease/blood ; Coronary Artery Disease/epidemiology ; Coronary Artery Disease/etiology* ; Diabetes Mellitus, Type 2/blood* ; Diabetes Mellitus, Type 2/complications* ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Humans ; Insulin Resistance/physiology ; Leptin/blood* ; Leptin/physiology ; Male ; Metabolic Syndrome/blood ; Metabolic Syndrome/epidemiology ; Metabolic Syndrome/etiology* ; Middle Aged ; Odds Ratio ; Prevalence ; Risk Factors
Coronary artery disease ; Hyperleptinemia ; Insulin resistance ; Metabolic syndrome
Leptin has been linked to adiposity, insulin resistance, and coronary artery disease (CAD). We examined whether the leptin concentrations are associated with the risk of CAD and metabolic syndrome (MS). The plasma leptin concentrations were measured in 556 diabetic patients (341 men and 215 women). The odds ratio (OR) of CAD and MS were increased on moving from the lowest quartile (Q1) of leptin concentration to the highest quartile (Q4) and remained significant after adjusting for age, sex, BMI, concentrations of total cholesterol, triglyceride, or high-sensitivity C-reactive protein (hsCRP), and treatment modalities for hyperglycemia. The frequency of CAD was highest in the insulin resistant group (Q4 of homeostasis model assessment-insulin resistance index [HOMA-IR]) at Q4 of leptin concentration (34.5%), compared with that of Q4 of leptin (26.4%) or HOMA-IR (21.9%). In multivariate analysis, plasma leptin concentration was identified as the most significantly independent predictor for CAD (OR 10.24, 95% CI 3.01 to 45.05). Other variables with associated with CAD were age, sex, hypertension, low-HDL cholesterolemia, and hsCRP. In conclusion, hyperleptinemia might be an independent risk factor for CAD and MS in diabetic subjects. And the simultaneous measurement of insulin resistance and leptin concentration might be helpful for screening subjects with a high-risk of CAD
Files in This Item:
T200801463.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Ahn, Chul Woo(안철우) ORCID logo https://orcid.org/0000-0003-3733-7486
Lee, Hyun Chul(이현철)
Lim, Sung Kil(임승길)
Cha, Bong Soo(차봉수) ORCID logo https://orcid.org/0000-0003-0542-2854
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.